{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:26:36Z","timestamp":1791293196842,"version":"4.1.0"},"reference-count":30,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Background: Opioid analgesic use and disorders have dramatically increased among the general American population and those receiving methadone maintenance treatment (MMT). Most research among MMT patients focuses on opioid analgesics misuse or disorders; few studies focus on MMT patients prescribed opioid analgesics. We describe demographic, clinical, and substance use characteristics of MMT patients prescribed opioid analgesics and compare them with MMT patients not prescribed opioid analgesics. Methods: We conducted a cross-sectional secondary data analysis using screening interviews from a parent study. From 2012 to 2015, we recruited adults from 3 MMT Bronx clinics. Questionnaire data included patterns of opioid analgesic use, substance use, comorbid illnesses, and demographic characteristics. Our main dependent variable was patients\u2019 report of currently taking prescribed opioid analgesics. To compare characteristics between MMT patients prescribed and not prescribed opioid analgesics, we conducted chi-square tests, t tests, and Mann-Whitney U tests. Results: Of 611 MMT patients, most reported chronic pain (62.0%), hepatitis C virus (HCV) infection (52.1%), and current use of illicit substances (64.2%). Of the 29.8% who reported currently taking prescribed opioid analgesics, most misused their opioid analgesics (57.5%). Patients prescribed (versus not prescribed) opioid analgesics were more likely to report human immunodeficiency virus (HIV) infection (adjusted odds ratio [aOR] = 1.6, 95% confidence interval [CI]: 1.1\u20132.3) and chronic pain (aOR = 7.6, 95% CI: 4.6\u201312.6). Conclusion: Among MMT patients primarily in 3 Bronx clinics, nearly one third reported taking prescribed opioid analgesics. Compared with patients not prescribed opioid analgesics, those prescribed opioid analgesics were more likely to report chronic pain and HIV infection. However, between these patients, there was no difference in illicit substance use. These findings highlight the complexity of addressing chronic pain in MMT patients.<\/jats:p>","DOI":"10.1080\/08897077.2015.1135225","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T16:47:17Z","timestamp":1452012437000},"page":"387-391","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":18,"title":["Characteristics of Methadone Maintenance Treatment Patients Prescribed Opioid Analgesics"],"prefix":"10.1177","volume":"37","author":[{"given":"Matthew C.","family":"Glenn","sequence":"first","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Sohler","sequence":"additional","affiliation":[{"name":"The City College of New York, Sophie Davis School of Biomedical Education, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Starrels","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Montefiore Medical Center, Division of General Internal Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeronimo","family":"Maradiaga","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Jost","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Montefiore Medical Center, Division of General Internal Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo O.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York, USA"},{"name":"Montefiore Medical Center, Division of General Internal Medicine, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"bibr1-08897077.2015.1135225","unstructured":"Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. NSDUH Series H-48, HHS Publication No. (SMA) 14\u20134863. http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUHresultsPDFWHTML2013\/Web\/NSDUHresults2013.pdf. Accessed August 13, 2015."},{"key":"bibr2-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.10.012"},{"key":"bibr3-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.02.012"},{"key":"bibr4-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.12.006"},{"key":"bibr5-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.07.007"},{"key":"bibr6-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00144-X"},{"key":"bibr7-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.11.011"},{"key":"bibr8-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.18.2370"},{"key":"bibr9-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00200-3"},{"key":"bibr10-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00391-2"},{"key":"bibr11-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2008.10.003"},{"key":"bibr12-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-0908-x"},{"key":"bibr13-08897077.2015.1135225","first-page":"327","volume":"17","author":"Merrill JO","year":"2002","journal-title":"J Gen Intern Med."},{"key":"bibr14-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2014.0234"},{"key":"bibr15-08897077.2015.1135225","unstructured":"Substance Abuse and Mental Health Services Administration. Managing Chronic Pain in People With or in Recovery From Substance Use Disorders: A Review of the Literature. Treatment Improvement Protocol (TIP) Series 54. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. HHS Publication No. (SMA) 12\u20134671. http:\/\/store.samhsa.gov\/shin\/content\/SMA12-4671\/TIP54.pdf. Accessed August 13, 2015."},{"key":"bibr16-08897077.2015.1135225","unstructured":"Cunningham C. Project FIRST\u2014Financial Incentives to Reduce Substance Use and Improve Treatment. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01376570. Accessed August 13, 2015."},{"key":"bibr17-08897077.2015.1135225","unstructured":"Cunningham C. Abstinence-reinforcing contingency management to reduce HIV viral load. National Institute of Health Research Portfolio Online Reporting Tools. https:\/\/projectreporter.nih.gov\/project_info_description.cfm?aid=8190763&icde=11210891&ddparam=&ddvalue=&ddsub=. Accessed August 13, 2015."},{"key":"bibr18-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2008.02.001"},{"key":"bibr19-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"bibr20-08897077.2015.1135225","unstructured":"World Health Organization. Alcohol Use Disorders Identification Test: Guidelines for use in Primary Care, Second Edition. Geneva, Switzerland: Department of Mental Health and Substance Dependence; 2001. http:\/\/apps.who.int\/iris\/bitstream\/10665\/67205\/1\/WHO_MSD_MSB_01.6a.pdf. Accessed August 13, 2015."},{"key":"bibr21-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2009.02376.x"},{"key":"bibr22-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2014.12091.x"},{"key":"bibr23-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03707.x"},{"key":"bibr24-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-002-0041-6"},{"key":"bibr25-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-1043-4"},{"key":"bibr26-08897077.2015.1135225","unstructured":"Substance Abuse and Mental Health Services Administration. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43. Rockville, MD: Center for Substance Abuse Treatment; 2005. HHS Publication No. (SMA) 12-4214. http:\/\/buprenorphine.samhsa.gov\/tip43_curriculum.pdf. Accessed August 13, 2015."},{"key":"bibr27-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1177\/070674370805300804"},{"key":"bibr28-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-11-201006010-00003"},{"key":"bibr29-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.05.021"},{"key":"bibr30-08897077.2015.1135225","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2007.00565.x"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2015.1135225","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2015.1135225","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2015.1135225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:47:11Z","timestamp":1777625231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2015.1135225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1080\/08897077.2015.1135225"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2015.1135225","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}